- Home
- HSTM
HSTM
HealthStream Inc.
as 12-20-2024 4:00pm EST
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | NASHVILLE |
| Market Cap: | 977.5M | IPO Year: | 2000 |
| Target Price: | $29.00 | AVG Volume (30 days): | 144.3K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.65 | EPS Growth: | 52.12 |
| 52 Week Low/High: | $23.92 - $33.52 | Next Earning Date: | 10-21-2024 |
| Revenue: | $287,992,000 | Revenue Growth: | 3.96% |
| Revenue Growth (this year): | 6.35% | Revenue Growth (next year): | 5.13% |
Latest HealthStream Inc. News
HSTM Breaking Stock News: Dive into HSTM Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
HSTM: Lowering target price to $34.00
Argus Research
11 days ago
HSTM: What does Argus have to say about HSTM?
Zacks
16 days ago
HSTM or ZS: Which Is the Better Value Stock Right Now?
Argus Research
18 days ago
HSTM: Raising target price to $35.00
Argus Research
25 days ago
HSTM: What does Argus have to say about HSTM?
Zacks
a month ago
HealthStream, Inc. (HSTM) Hit a 52 Week High, Can the Run Continue?
Simply Wall St.
a month ago
Returns On Capital Are Showing Encouraging Signs At HealthStream (NASDAQ:HSTM)
Argus Research
a month ago
HSTM: Raising target price to $34.00
Compare HSTM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HSTM HealthStream Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.